Guttman-McCabe Christopher 4
4 · Anterix Inc. · Filed May 19, 2022
Insider Transaction Report
Form 4
Anterix Inc.ATEX
Guttman-McCabe Christopher
Chief Reg & Comm Officer
Transactions
- Award
Common Stock
2022-05-17+12,655→ 68,576 total - Award
Stock Option (Right to Buy)
2022-05-17+25,511→ 25,511 totalExercise: $49.39Exp: 2032-05-17→ Common Stock (25,511 underlying)
Footnotes (2)
- [F1]Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest and become exercisable on May 17, 2023, with the remaining RSUs vesting in 3 equal annual installments thereafter.
- [F2]25% of the option shares vest and become exercisable on May 17, 2023, with the remaining option shares vesting in 3 equal annual installments thereafter.